356 related articles for article (PubMed ID: 15231860)
21. Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer.
Sym SJ; Chang HM; Ryu MH; Lee JL; Kim TW; Yook JH; Oh ST; Kim BS; Kang YK
Ann Surg Oncol; 2010 Apr; 17(4):1024-32. PubMed ID: 19941081
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant chemotherapy with a combination of irinotecan and cisplatin in advanced gastric cancer--a case report.
Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Kameda Y; Noguchi Y
Hepatogastroenterology; 2000; 47(36):1575-8. PubMed ID: 11149004
[TBL] [Abstract][Full Text] [Related]
23. Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trial.
Nishikawa K; Fujitani K; Inagaki H; Akamaru Y; Tokunaga S; Takagi M; Tamura S; Sugimoto N; Shigematsu T; Yoshikawa T; Ishiguro T; Nakamura M; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J; Tsujinaka T
Eur J Cancer; 2015 May; 51(7):808-16. PubMed ID: 25797356
[TBL] [Abstract][Full Text] [Related]
24. [A gastric cancer patient with marked para-aortic lymph node metastasis surviving more than 10 years after aggressive operation and repeated EAP chemotherapy].
Uchinami M; Horiuchi T; Aotake T; Matsumura M; Yokomachi J; Tanaka K; Tabo T; Tanigawa N
Gan To Kagaku Ryoho; 2002 Mar; 29(3):449-53. PubMed ID: 11915738
[TBL] [Abstract][Full Text] [Related]
25. Third-line chemotherapy with paclitaxel, irinotecan hydrochloride and cisplatin for recurrent gastric cancer: a case report.
Takahashi N; Suzuki H; Iwabuchi S; Yamazaki Y; Yanaga K
Hepatogastroenterology; 2005; 52(61):326-8. PubMed ID: 15783061
[TBL] [Abstract][Full Text] [Related]
26. Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis.
Sakamoto T; Yasui H; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamazaki K; Taku K; Machida N; Todaka A; Tomita H; Tsushima T; Taniguchi H; Hamauchi S
Int J Clin Oncol; 2010 Jun; 15(3):287-93. PubMed ID: 20217447
[TBL] [Abstract][Full Text] [Related]
27. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
[TBL] [Abstract][Full Text] [Related]
29. Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer.
Kucukzeybek Y; Dirican A; Erten C; Somali I; Can A; Demir L; Bayoglu IV; Akyol M; Medeni M; Tarhan MO
Asian Pac J Cancer Prev; 2012; 13(6):2771-4. PubMed ID: 22938457
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial.
Di Bartolomeo M; Buzzoni R; Mariani L; Ferrario E; Katia D; Gevorgyan A; Zilembo N; Bordonaro R; Bochicchio AM; Massidda B; Ardizzoia A; Marini G; Aitini E; Schieppati G; Comella G; Pinotti G; Palazzo S; Cicero G; Bajetta E; ; Villa E; Fagnani D; Reguzzoni G; Agostana B; Oliani C; Kildani B; Duro M; Botta M; Mozzana R; Mantovani G
Oncology; 2006; 71(5-6):341-6. PubMed ID: 17855795
[TBL] [Abstract][Full Text] [Related]
31. [A case of advanced gastric carcinoma with disappearance of cancer cells by neoadjuvant chemotherapy].
Nakagawachi T; Yunotani S; Nakamura M; Samejima R; Shida T; Yonemitsu N; Eguchi T; Miyazaki K
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1955-8. PubMed ID: 9797819
[TBL] [Abstract][Full Text] [Related]
32. [A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor].
Nakayama N; Tanabe S; Koizumi W; Higuchi K; Sasaki T; Nakatani K; Shimoda T; Nishimura K; Kobayashi N; Mitomi H; Saigenji K
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1641-4. PubMed ID: 17108732
[TBL] [Abstract][Full Text] [Related]
33. [A case of advanced gastric cancer with peritoneal dissemination responding remarkably to TS-1/CDDP combination chemotherapy].
Nishiura H; Ishii K; Nonami M; Shigemori M; Katsurada A; Azechi H; Kondo M; Tojo M; Nishikawa K; Asagoe K; Otani Y; Inoue F; Suwa H; Saiga T
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2057-60. PubMed ID: 17197753
[TBL] [Abstract][Full Text] [Related]
34. [A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP therapy].
Kameyama H; Nashimoto A; Yabusaki H; Takii Y; Tsuchiya Y; Tanaka O; Ohta T
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1485-8. PubMed ID: 14584282
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy of low-dose CDDP and CPT-11 for patients with intestinal type of gastric adenocarcinoma].
Nagahori Y; Nagahori K; Hamaguchi Y; Fukushima T; Masui H; Mogaki M; Abe T
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1555-9. PubMed ID: 18799911
[TBL] [Abstract][Full Text] [Related]
36. Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.
Ajani JA; Mayer RJ; Ota DM; Steele GD; Evans D; Roh M; Sugarbaker DJ; Dumas P; Gray C; Vena DA
J Natl Cancer Inst; 1993 Nov; 85(22):1839-44. PubMed ID: 8230264
[TBL] [Abstract][Full Text] [Related]
37. [A case of stage IV gastric carcinoma with lymph nodes metastases of the paraaorta responding markedly to TS-1].
Itoh H; Bando E; Kawamura T; Ii T; Takegawa S; Kiriyama M; Dohba S; Kojima Y; Watanabe K
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2549-53. PubMed ID: 12506481
[TBL] [Abstract][Full Text] [Related]
38. Phase 1/11 study of bi-weekly irinotecan plus cisplatin in the treatment of advanced gastric cancer.
Koizumi W; Kurihara M; Satoh A; Takiuchi H; Tanabe S; Shimada K; Iwasaki R; Saigenji K
Anticancer Res; 2005; 25(2B):1257-62. PubMed ID: 15865075
[TBL] [Abstract][Full Text] [Related]
39. [Two cases of advanced gastric cancer achieved pathological complete response by preoperative chemotherapy with S-1 plus weekly low-dose CDDP].
Kono E; Tanaka N; Kudo K; Musha H; Tsuchiya T; Miyachi T; Nagao M; Kajiwara T; Kimura S; Karasawa H; Aoki T; Abe T; Ohnuma S; Nakagawa K; Morikawa T; Yoshida H; Motoi F; Katayose Y; Naito T; Unno M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2279-81. PubMed ID: 25731495
[TBL] [Abstract][Full Text] [Related]
40. [A case of gastric cancer with paraaortic lymph node metastasis responding to TS-1/CDDP combination therapy].
Konno S; Katsube T; Obu M; Murayama M; Hamaguchi K; Shimakawa T; Naritaka Y; Yagawa Y; Ogawa K; Aiba M
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2021-4. PubMed ID: 15570932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
